Drug-coated balloon treatment during emergency angioplasty for STEMI

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry enrolls patients presenting with ST-elevation myocardial infarction who undergo primary percutaneous coronary intervention using a drug-coated balloon-based strategy. Procedural details, in-hospital events, and follow-up clinical outcomes will be collected to characterize safety and efficacy in the acute STEMI setting. Key exclusions include in-stent culprit lesions, recent stent implantation, contraindications to antiplatelet therapy, cardiac arrest/intubation, cardiogenic shock, or expected life-expectancy under one year. The registry is conducted at the Medical University of Vienna (Universitatsklinikum AKH Wien).

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All ST-elevation MI undergoing Primary PCI

Exclusion Criteria:

* In-stent culprit lesion
* Contraindications to antiplatelets
* Stent implantation within 3 months before enrollment
* Cardiac arrest, intubation, or cardiogenic shock
* Life-expectancy less than one year

Where it's running

• Universitatsklinikum AKH wien
  Vienna, Austria Recruiting

Study contacts

• Principal investigator: Rayyan Hemetsberger, MD — Universitatsklinikum AKH wien
• Study coordinator: Riccardo Terzi, MD, BSc
• Email: riccardo.terzi1@gmail.com
• Phone: +393312127467

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Smartphone AI help for prehospital ECG readings

  This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.

  Recruiting École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care · Murten/Morat, Canton of Fribourg · NCT07810686

• Targeted look at residual inflammation after a heart attack

  This project will test whether the neutrophil-to-lymphocyte ratio (NLR) from the first routine blood draw can help predict risk of death in adults (18–85) after an acute coronary syndrome treated with PCI.

  Recruiting University Hospital Centre Mother Teresa · Tirana · NCT07026708

• Risk of malignant arrhythmias after acute coronary syndrome

  This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07824050

• Rapid guideline-based therapy after a heart attack

  This project tests whether starting guideline-driven secondary prevention soon after a heart attack helps people who had PCI reach better risk-factor control and fewer heart events.

  Recruiting Zuyderland Medisch Centrum · Heerlen, Limburg · NCT07773272

• Optimal timing of staged complete revascularization in STEMI with multivessel disease

  This trial tests whether performing staged complete revascularization during the hospital stay or after discharge is best for STEMI patients with multivessel disease.

  Recruiting Chonnam National University Hospital · Bucheon-si and 29 other locations · NCT07741721

• Early single antiplatelet therapy after IVUS-guided PCI in ACS

  This study tests whether stopping aspirin early and continuing a potent P2Y12 inhibitor alone is safe and effective after IVUS-guided PCI in people with acute coronary syndrome.

  Recruiting Phase 4 Gyeongsang National University Hospital · Jinju, Gyeongsangnam-do · NCT07684742

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.